Heather Kertland is a Clinical Pharmacy Specialist/Leader in the Heart, Vascular and Respiratory Program at St Michael’s Hospital, Unity Health Toronto. Her area of clinical expertise is cardiovascular diseases, in particular acute coronary syndromes and arrhythmias.
She teaches in the Doctor of Pharmacy Program and the PharmD for Pharmacist programs and has been named Instructor of the Year three times.
Heather holds an appointment in the Graduate Department of Pharmaceutical Sciences. Her area of research focus is patient safety, exploring the safe and effective use of medications in a hospitalized patient population.
Select Publications
Dryden L, Kertland H. For patients who have an indication for oral anticoagulation for atrial fibrillation and dual antiplatelet therapy post PCI– double therapy is preferred over triple therapy. Can J Hosp Pharm 2019;72:764-767.
Kertland H, Satchu S, Chant C, Garland J, Tom E. Safety Rounds – A Patient Safety Initiative. Can J Hosp Pharm 2018;71:385-388.
Samantha Tri S, Albers, Koshman S, Bucci C, Kertland H, Semchuk W. Dual Antiplatelet Therapy: A New Whiteboard Video for Patient Education. CPJ 2018:151:368-71.
Leung A, Kertland H. Should digoxin continue to be used for the management of atrial fibrillation? The Con Can J Hosp Pharm 2017; 70:392-394.
